Podcast Episodes

Back to Search
QA Mistakes That Keep Weak Quality Systems Alive

Many of the most common mistakes in Quality Assurance are not caused by a lack of technical knowledge. They result from how organizations think about…

5 months, 3 weeks ago

Short Long
View Episode
Risk Management in Pharma: Lessons from Artemis II

The Artemis II mission offers a powerful analogy for how pharmaceutical organizations should approach readiness, risk management, and system reliabil…

5 months, 3 weeks ago

Short Long
View Episode
The LISTEN Model: Better Thinking for Pharma QA

Strong Quality Assurance professionals do more than make decisions — they listen.

In this episode of The GMP Insider, we introduce the LISTEN Model, …

6 months ago

Short Long
View Episode
"Retraining" Is the Most Overused CAPA in Pharma — Here's Why

Retraining is one of the most common corrective actions used in pharmaceutical investigations — but it is often applied even when the true issue is n…

6 months ago

Short Long
View Episode
Why People Stay Silent in Weak Quality Cultures

One of the clearest indicators of a weak quality culture is when employees hesitate to report problems.

In strong organizations, people raise deviati…

6 months, 2 weeks ago

Short Long
View Episode
"We've Always Done It This Way": Pharma's Most Dangerous Phrase

“We've always done it this way” is one of the most dangerous mindsets in pharmaceutical quality systems.

As processes evolve, regulations change, and…

6 months, 2 weeks ago

Short Long
View Episode
Activity vs Effectiveness: What FDA Really Wants to See

In Quality Assurance, activity is often mistaken for effectiveness. CAPAs are closed, training is completed, and SOPs are revised — but the underlyin…

6 months, 2 weeks ago

Short Long
View Episode
"Human Error" Is Not a Root Cause: QA Investigation Mistake

“Human error” is one of the most common conclusions in pharmaceutical quality investigations — but it is rarely the true root cause.

In this episode …

6 months, 2 weeks ago

Short Long
View Episode
How FDA Inspects Biologics: Risk-Based GMP Explained

Episode 22

Biological drug products present unique manufacturing and quality challenges due to their complexity, aseptic processing requirements, and critical p…

6 months, 2 weeks ago

Short Long
View Episode
AI Meets FDA: Why Credibility Beats Capability in Pharma

Episode 21

Artificial Intelligence is becoming increasingly important across the pharmaceutical industry, influencing clinical trials, manufacturing, pharmacovi…

6 months, 2 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us